Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.

Erb K, Pechstein B, Schueler A, Engel J, Hermann R

Open source

DOI
10.1067/mcp.2000.106894
Published
2000 Jun
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mcp.2000.106894,
  title = {Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.},
  author = {Erb K and Pechstein B and Schueler A and Engel J and Hermann R},
  year = {2000},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1067/mcp.2000.106894},
  url = {https://doi.org/10.1067/mcp.2000.106894}
}

RIS

TY  - JOUR
TI  - Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
AU  - Erb K
AU  - Pechstein B
AU  - Schueler A
AU  - Engel J
AU  - Hermann R
PY  - 2000
JO  - Clinical pharmacology and therapeutics
DO  - 10.1067/mcp.2000.106894
UR  - https://doi.org/10.1067/mcp.2000.106894
ER  - 

APA

K, E., B, P., A, S., J, E., & R, H. (2000). Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.. Clinical pharmacology and therapeutics. https://doi.org/10.1067/mcp.2000.106894

Source records